Beijing: China has reportedly approved patent for CanSino Biologics Inc’s COVID-19 vaccine — Ad5-nCOV. It is the first patent granted by China for a COVID-19 vaccine.
Saudi Arabia will be carrying out the Phase-III clinical trials for the CanSino vaccine this month.
CanSino is exploring testing the vaccine in Russia, Brazil and Chile as well. CanSino’s Hong Kong shares rose by around 14 per cent on Monday.
Also Read: First Batch Of Russian COVID-19 Vaccine To Roll Out This Month
Bhubaneswar: The India Meteorological Department (IMD) has issued a nowcast warning for three districts of Odisha till 4.30 pm on...
Boudh (Odisha): The Forest Wing of Odisha Vigilance seized a leopard skin following a surprise raid at Karanjkata village in Boudh...
Bhubaneswar: Team Shadow Warriors, featuring esports athletes from Bhubaneswar, secured a top-8 position in the National Esports Championship 2026 in...
New Delhi: The planned dedication of the HPCL Rajasthan refinery by Prime Minister Narendra Modi on April 21 has been postponed...
Copyright © 2026 Frontier Media
